SystemManufacturing & Quality

The complete guide · November 2026

Validation document automation, explained.

Every new bioreactor or pouch sealer in a regulated plant has to prove itself on paper before it makes anything a patient will use. The proof starts with three test plans, called IQ, OQ and PQ protocols, which fix each test and its pass mark in advance. Much of the time spent on one goes to finding the right documents and copying numbers out of them, and that is the part software can now draft for a person to check.

This guide is for validation engineers and leads, automation and process engineers, quality assurance (QA) approvers and site quality heads at drug, biotech, device and contract manufacturing companies. It also serves leaders deciding whether to automate the paperwork. No background needed.

See one case, screen by screen →
Watch with transcript →
A quick example · fictional

Imagine you are a validation engineer at a plant in Leiden that makes medicines from living cells. This week's job is OQ-BR204-001, the operational qualification protocol for BR-204, a new 500 liter bioreactor, the tank that grows those cells. Its installation record was approved on September 18, 2026. Fourteen user requirements sit behind the protocol, it holds 31 test steps, and you have been copying setpoints, the values the machine is told to hold, out of a 46-page supplier specification.

At 9:02 am on October 6, a new revision of the requirements arrives, approved by your head of quality. One line on page 4 has changed. A new cell line needs the tank to drop to 28.0 °C on day 5, and QA has tightened temperature control. Before anyone runs a test, you have to say which tests that line touches.

Requirement URS-021, revision 3
Range
30.0–40.0 °C
Control
±0.5 °C
Requirement URS-021, revision 4
Range
28.0–40.0 °C
Control
±0.3 °C
Four test cases link to this requirementThree must be rewritten and one standsbecause 9.2-02 still accepts 36.5–37.5 °C where 36.7–37.3 °C is now needed, 9.2-03 still accepts ±0.5 °C, and 9.2-04 tests 30.0 °C and misses the new low end.

Good protocol work catches this at the desk. Missed, a test passes against a limit nobody holds anymore, or a deviation, a recorded departure from the plan, opens on the floor with the bioreactor occupied.

Validation document automation guide
Part A · Understand it

IQ, OQ and PQ protocols: what they prove, what they are written from and where the paperwork fails

This part names no product. It explains the work, the rules as they stand in November 2026, the arithmetic behind an acceptance range, what FDA has written up, and what regulators say about AI drafting these documents. The bioreactor in the example is fictional, and the rules and letters are real.

01 · In plain words

A machine earns its place in a plant through documents written before it runs

A drug plant buys a bioreactor, a steel tank that grows the living cells that make a medicine. A device plant buys a heat sealer that closes sterile pouches. Neither machine may simply be switched on and used. Regulators expect the company to show, with records, that this machine is fit for this job. Showing it for a machine is called qualification. Showing it for a whole manufacturing process is called validation, and qualified equipment is one of the things process validation stands on.

The proof comes in three stages with three short names. Installation qualification, or IQ, checks that the machine was installed as designed. Operational qualification, or OQ, checks that it runs across its full range. Performance qualification, or PQ, checks that it does the real job under real conditions. Each stage starts with a protocol: a test plan that lists every step, the expected result and what counts as a pass. People approve the plan first, so nobody can pick the pass mark after seeing the answer.

Writing that plan looks like engineering, and part of it is. Much of it is clerical. The author opens the company's locked template, then goes hunting. The operating range is in the user requirements. The drive limit is in the supplier's design specification. The instrument tag is in the installation report. The reference thermometer's accuracy and due date are on a calibration certificate. Each value is found, read in context and retyped with its unit.

Then a table has to tie every requirement to the tests that prove it, usually in a spreadsheet beside the protocol. And the sources keep moving. A requirement gets a new revision, or a drawing does. Someone has to work out which tests just went out of date, usually by reading the protocol again. Validation document automation means software that does the finding, copying and comparing, cites the page for each value, and leaves the decisions and signatures to qualified people.

How a bioreactor goes from a written requirement to staying qualified

  1. Say what you needThe site writes a user requirements specification, or URS: ranges, tolerances, alarms, what the machine must do.
  2. Check the designThe supplier answers with a functional and design specification. The site checks the design against the URS, and may test at the factory.
  3. Write and approve the protocolsIQ, OQ and PQ plans are drafted from those approved records, with a trace back to each requirement. This step is the subject of this guide.
  4. Run and recordPeople run the tests on the machine and record actual results. Anything off plan becomes a deviation. A report sums it up against the acceptance criteria.
  5. Keep it trueEvery later change to the machine, its requirements or its software is assessed for what it does to the qualified state.

Step 3 is the subject of this guide, and changes in step 5 send people back to it. The people, plant and figures in the example are fictional.

Surprises in qualification paperwork, from FDA's missing labels to a value that exists nowhere

FDA's drug rules never say IQ, OQ or PQ

21 CFR 211.63 asks for equipment of appropriate design "for its intended use", and 211.68 for routine calibration and checks.1,2 The three labels come from common practice and two other texts: EU Annex 15, the EU's manufacturing rules on qualification and validation, and ICH Q7, the international guide for active ingredients.3,4 FDA's warning letters, its notices of what it believes are significant violations, use the labels with drug makers all the same.5,6,7

The plan comes before the test, and a change to it has a price

Under Annex 15, a significant change to an approved protocol during execution "should be documented as a deviation and be scientifically justified".3 A number fixed at the desk costs an edit. The same number fixed on the floor costs an investigation.

A perfect test could count for nothing in Europe

The draft revision of EU Annex 11 says test cases not traceable to requirements or specifications "do not meet the requirements to qualification and validation".8 It is a draft and covers computerized systems, but it shows where inspectors' thinking has gone.

The value you need may exist nowhere

In the example, the supplier's alarm table leaves the high dissolved oxygen setpoint "to be set at commissioning", the equipment's setup and first start. No copying fixes that, and someone has to decide. By hand, gaps like this tend to surface late, when the test step has no expected result to write down.

URS, protocol, acceptance criterion and trace matrix: the words on every page

URS

User requirements specification. Annex 15 calls it "a point of reference throughout the validation life cycle".3 It says what the machine must do, in the site's words.

Protocol

The approved test plan for a stage. Annex 15 asks that it define "the critical systems, attributes and parameters and the associated acceptance criteria".3

Acceptance criterion

The result that counts as a pass, fixed in advance. In the example: the temperature probe reads 36.7–37.3 °C at a 37.0 °C setpoint.

Trace matrix

A table linking each requirement to its specification clause, its design record and the tests that prove it. Also called a requirements traceability matrix, or RTM.

Fourteen terms are defined in the one-page summary.

02 · IQ, OQ and PQ

IQ vs OQ vs PQ: what each stage proves, and which document it answers to

In shortIQ asks whether the machine was installed as designed, OQ whether it runs across its range, and PQ whether it does the real job. EU Annex 15 lays out the stages from requirement to performance, and it lets a site combine them where that is justified.

Annex 15 runs from a written requirement to a performance test, and each stage is released before the next

The main stages, with what each one checks. GMP is good manufacturing practice.

  1. 1URS

    What the machine must do. Quality is built in here, and GMP risks are reduced to an acceptable level.

    SiteSection 3.2
  2. 2DQ

    Design qualification: the design is checked against GMP, and the URS is verified.

    Site with supplierSection 3.3
  3. 3FAT and SAT

    Factory and site acceptance tests. Some tests need not repeat if transport and installation do not affect them.

    Supplier and siteSections 3.4–3.7
  4. 4IQ

    Installation against drawings and specifications, calibration, materials of construction.

    ValidationSections 3.8–3.9
  5. 5OQ

    Tests of operating limits, upper and lower, and worst case conditions.

    ValidationSections 3.10–3.12
  6. 6PQ

    Production material or a proven substitute, under normal conditions with worst case batch sizes.

    ValidationSections 3.13–3.14

Our reading of the sources 3

Show the numbers
StepWhat happensWhoTime
URSWhat the machine must do. Quality is built in here, and GMP risks are reduced to an acceptable level.SiteSection 3.2
DQDesign qualification: the design is checked against GMP, and the URS is verified.Site with supplierSection 3.3
FAT and SATFactory and site acceptance tests. Some tests need not repeat if transport and installation do not affect them.Supplier and siteSections 3.4–3.7
IQInstallation against drawings and specifications, calibration, materials of construction.ValidationSections 3.8–3.9
OQTests of operating limits, upper and lower, and worst case conditions.ValidationSections 3.10–3.12
PQProduction material or a proven substitute, under normal conditions with worst case batch sizes.ValidationSections 3.13–3.14

ICH Q7, the good manufacturing practice (GMP) guide for active ingredients, gives the shortest definitions. IQ is documented verification that equipment "as installed or modified" complies with the approved design, the manufacturer's recommendations or user requirements. OQ shows it performs as intended "throughout the anticipated operating ranges". PQ shows that equipment and its ancillary systems, connected together, "can perform effectively and reproducibly".4

FDA's 2011 process validation guidance describes the same work with no labels: verifying equipment is built and installed to the design, and verifying it operates "in all anticipated operating ranges".9

StageThe question it answersTested againstOn the example's bioreactor
IQIs what arrived what was specified, and is it connected and calibrated?Design specification and drawings500 liter vessel V-204 in 316L steel, temperature probe TT-204-01 calibrated September 9
OQDoes each function work across its range, at its limits and when it fails?Functional specificationTemperature at 28.0, 37.0 and 40.0 °C, agitation, gas flows, alarms, restart after a power cut, log-ins
PQDoes it do the real job, consistently, in real conditions?User requirementsRuns with product or a proven substitute, for a later protocol

The pairing in the third column is how PIC/S, the inspectors' co-operation scheme, tells inspectors to read a computerized system's file: "PQ versus URS", "OQ versus FS" and "IQ versus DS or DR".10 Many sites apply the same pairing to equipment.

Qualification vs validation, and how a device maker's process validation uses the same three letters

In drug manufacturing, equipment is qualified and processes are validated, and Annex 15 says computerized systems "should also be validated according to the requirements of Annex 11".3 FDA told one drug firm that qualification of equipment "is an integral part of your process validation program".6

Device makers use IQ, OQ and PQ for process validation itself. FDA's 2015 device training slides describe IQ as whether "everything" is "installed correctly" and OQ as challenging process parameters to assure the process makes product that meets requirements, with a heat sealer as the worked case. They draw on a 2004 Global Harmonization Task Force guidance, which we read only through these slides.11

Since February 2, 2026 the device rule is the Quality Management System Regulation (QMSR), which incorporates ISO 13485:2016 by reference.12 FDA's device inspection program now lists validation of processes under clause 7.5.6 of that standard.13 So a site that runs both kinds of product can hold two sets of rules over one document format.

What an OQ protocol template contains, section by section

WHO's guideline on qualification says a protocol should specify prerequisites and test details, including acceptance criteria, and a report should follow each protocol or stage.14 Annex 15 adds approval by the appropriate people, critical parameters, and a formal release to the next stage.3 The rest is house style, held in a locked template. The example's OQ template has 21 sections:

Part of the protocolSectionsWhere the content comes from
Front matterApprovals, purpose, scope, responsibilities, referencesLocked wording, the URS title and revision, the site's validation master plan
The machineSystem description, prerequisites, test instrumentsIQ report, drawings, calibration certificates
The testsAlarms, temperature, agitation, dissolved oxygen, pH, pressure, gas flow, power-failure recovery, access and audit trailURS for what is asked, design spec for limits, the author for how to prove it
The closeDeviations, acceptance and conclusionLocked wording
Scaling the file to risk. Annex 15 says decisions on the scope and extent of qualification should rest on "a justified and documented risk assessment".3 The commissioning and qualification guide from ISPE, the pharmaceutical engineering society, second edition, June 2019, is sold, so we read its publisher's page, which describes a system risk assessment that identifies critical aspects and critical design elements.15 A protocol that tests everything because nobody decided what mattered costs time twice, once to write and once to run.
03 · The source records

The six records behind one OQ protocol, and which values each one supplies

In shortAn OQ protocol quotes other controlled documents. In the example, six records and 157 pages supply 19 values and every requirement. Before copying anything, the author has to establish that each record is the current approved revision.

Most of the reading behind the example's protocol is the supplier's paperwork

Pages in each of the six source records; the supplier's two come to 98 of 157

Factory acceptance test report52 pages
Functional design specification46 pages
Installation qualification report32 pages
User requirements specification18 pages
Calibration certificates6 pages
Piping and instrumentation diagram3 pages

Fictional example from this guide

Show the numbers
ItemValue
Factory acceptance test report52 pages
Functional design specification46 pages
Installation qualification report32 pages
User requirements specification18 pages
Calibration certificates6 pages
Piping and instrumentation diagram3 pages
RecordWho writes itWhat the protocol takes from itThe example's value
URS, revision 4The siteRanges, tolerances, response times28.0–40.0 °C, ±0.3 °C (page 4)
Functional design spec, revision BSupplierLimits, control logic, alarm tableDrive limited to 140 rpm at 400 L (page 15)
IQ report, approvedSite validationTags, instrument types, software version, the approval dateController software v5.2.1, approved September 18, 2026
P&ID, revision 5EngineeringVessel and valve tags, materialsV-204, 500 L, 316L, jacketed
Calibration certificatesSite calibration labReference instruments, accuracy, due datesThermometer TR-07, ±0.05 °C, due January 15, 2027
Factory test reportSupplierWhat was measured before shipping, and tests that need not repeat140.4 rpm measured at the drive limit

P&ID means piping and instrumentation diagram. A seventh record, the alarm list of a matching bioreactor called the sister unit, enters the example only as a suggestion, in section 8.

Why copying a setpoint from a design spec takes longer than it sounds

The value has to carry its unit exactly as written, because "60 % air saturation" and "60 %" are different claims. It may sit in a table with a footnote that changes its meaning: the example's alarm table notes that its setpoints are defaults for the 37.0 °C recipe. It may be scanned. It may differ between revisions, and a superseded copy may be the one in someone's folder. The author also has to check it against every other source that mentions it, which is how a disagreement gets found.

Annex 15 says the inter-relationship between documents in complex validation projects "should be clearly defined", and that appropriate checks should ensure "the integrity of all data obtained".3 For documents held in computer systems, 21 CFR 211.68(b) requires that input and output "shall be checked for accuracy".2 A site's own procedure often turns this into a second-person check, which adds that person's hours. Part 211 sets no format for that check, and the degree of verification depends on the system's complexity and reliability.2

04 · The rules and their dates

Annex 15, 21 CFR 211, ISO 13485: who asks for qualification and in what words, as of November 2026

In shortEU Annex 15 is the fullest text and has stood since 2015, with a revision planned: a draft in December 2026 and publication in April 2028. FDA binds drug makers through Part 211 and explains itself in a 2011 guidance. Device makers moved to ISO 13485 under the QMSR on February 2, 2026. The draft EU Annex 11 and Annex 22 are still drafts.

The rules behind qualification documents changed most on the device side in 2026, and EU drafts are still pending
  1. Jan 2011FDA process validation guidance

    Three stages; equipment qualification sits in stage 2.

  2. Jan 2011EU Annex 11 revision

    In operation June 30, 2011. Still the current text.

  3. Oct 1, 2015EU Annex 15 in operation

    URS to PQ, change control, no retrospective validation.

  4. Jul 7, 2025Draft Annex 11 and Annex 22 out

    Consultation runs to October 7, 2025.

  5. Feb 2, 2026FDA QMSR effective

    ISO 13485:2016 incorporated into device rules.

  6. Feb 3, 2026FDA Computer Software Assurance guidance, current version

    Device production and quality system software.

Source 3,16,17,18,9,12,19,20

Show the numbers
WhenWhat
Jan 2011FDA process validation guidance
Jan 2011EU Annex 11 revision
Oct 1, 2015EU Annex 15 in operation
Jul 7, 2025Draft Annex 11 and Annex 22 out
Feb 2, 2026FDA QMSR effective
Feb 3, 2026FDA Computer Software Assurance guidance, current version
Q4 2026Inspectors' target for Annex 11 and Annex 22
Dec 2026Annex 15 revision: draft planned
TextStatusWhat it says about these documents
EU GMP Annex 15In operation October 1, 2015, and still the current text.17 A revision is planned: concept paper consulted on February 9 to April 9, 2026; draft for consultation December 2026; comments to March 2027; inspectors' endorsement November 2027; Commission publication and PIC/S adoption April 2028.20Protocols with critical parameters and acceptance criteria (2.4), approval (2.2), deviations (2.7, 2.8), URS as point of reference (3.2), OQ limits (3.11), change control (section 11). A third party's protocols need the site's confirmation before approval (2.6).3
EU GMP Annex 11January 2011 revision, still listed17For computerized systems: user requirements "should be traceable throughout the life-cycle" (4.4); validation documents include change control records and deviations (4.2).16
Draft Annex 11, draft Annex 22Drafts, consultation closed October 7, 2025.21 Q4 2026 is a target for final text18Documented traceability from requirements to design to test cases, "established and maintained" (draft 11, 6.5, 9.5).8 Limits on AI in critical GMP uses (draft 22; see section 12).22
21 CFR 211.22, 211.63, 211.68, 211.100In force; 2025 CFR edition is the newest on govinfoEquipment fit for intended use; calibration and checks to a written program; only authorized changes to records; procedures and their changes drafted, reviewed and approved, then reviewed and approved by the quality unit.23,1,2,24
FDA process validation guidanceJanuary 2011, nonbindingQualification plans name the tests, criteria, timing, responsibilities and approval, and the firm's requirements for evaluating changes. "The quality control unit must review and approve the qualification plan and report".9
ICH Q7, section 12Final (ICH Step 4), November 10, 2000For active ingredients: written validation protocols reviewed and approved by the quality unit, and DQ, IQ, OQ and PQ defined.4
21 CFR 820 (QMSR) and ISO 13485:2016Effective February 2, 2026Replaced the Quality System Regulation for devices.12 The rule reserves Subparts C to O, the old home of 21 CFR 820.75.25 FDA's inspection program lists validation of processes under clause 7.5.6, and FDA began inspecting under that program on February 2, 2026.12,13
WHO TRS 1019, Annex 3, Appendix 62019The URS "should be used when selecting the required item from an approved supplier, and to verify suitability throughout the subsequent stages of qualification".14
21 CFR 11.10, 11.50In forceIf a protocol is signed electronically: system validation, audit trails, and each signature showing the printed name, the date and time, and its meaning.26,27
Only draft EU Annex 11 spells out the requirement-to-test link; US drug rules leave it to the firm

How directly each text addresses five things a protocol file must show. Our reading of each text.

SilentImpliedAddressedSpelled out
Written requirementsTrace to testsApproved planUpper and lower limitsChange re-assessedEU Annex 15Spelled outImpliedSpelled outSpelled outSpelled outEU Annex 11 (systems)Spelled outAddressedImpliedAddressedAddressedDraft EU Annex 11 (systems)Spelled outSpelled outSpelled outSpelled outSpelled outFDA 2011 guidanceImpliedSilentSpelled outAddressedAddressed21 CFR 211ImpliedSilentAddressedSilentAddressedICH Q7ImpliedSilentSpelled outAddressedAddressed

Our reading of the sources 3,16,8,23,1,2,24,9,4

Show the numbers
Written requirementsTrace to testsApproved planUpper and lower limitsChange re-assessed
EU Annex 15Spelled outImpliedSpelled outSpelled outSpelled out
EU Annex 11 (systems)Spelled outAddressedImpliedAddressedAddressed
Draft EU Annex 11 (systems)Spelled outSpelled outSpelled outSpelled outSpelled out
FDA 2011 guidanceImpliedSilentSpelled outAddressedAddressed
21 CFR 211ImpliedSilentAddressedSilentAddressed
ICH Q7ImpliedSilentSpelled outAddressedAddressed
Where FDA's Computer Software Assurance guidance fits. The current version, February 3, 2026, covers "computers or automated data processing systems used as part of production or the quality management system for medical devices".19 It concerns software. It does not govern the qualification of a drug plant's bioreactor. For a device maker it does reach production and quality system software, and its risk framework names "artificial intelligence/machine learning tools" when used that way, so a drafting tool in a device maker's quality system may itself fall in scope.19 CDER, FDA's drug center, has issued no counterpart; its July 2026 agenda lists a planned supplement on AI-based systems, and an agenda does not bind CDER to publish it.28 The computer software assurance guide covers that method in full.

GAMP 5, second edition, July 2022, is ISPE's industry guide for computerized systems. It is sold, and we read only its publisher's page, so this guide quotes no requirement from it.29 It has no force of law.

05 · The trace matrix

The requirements traceability matrix: what each column proves and why it drifts from the protocol

In shortA trace matrix links each requirement to its specification clause, its design record and its numbered tests. EU Annex 11 asks for traceable requirements today, and draft Annex 11 names the matrix. The rows that repay the effort are the ones that show a gap or a disagreement.

Read forward, a trace matrix answers the approver's question: is every requirement proved somewhere? Read backward, it answers the inspector's: why is this test here? In equipment work it has more than two links, because a requirement written by the site is answered by a supplier's clause, built as a design record and proved by a test.

RequirementFunctional specDesign recordTestsState
URS-020 working volume 100–400 L in a 500 L vesselFDS 4.1, p. 8P&ID sheet 19.2-01Traced
URS-022 agitation 20–150 rpm, ±2 rpmFDS 6.3, p. 15: limited to 140 rpm at 400 LIQ report §8.39.3-01 to -03Specs disagree
URS-026 clean-in-placeFDS 9.1, p. 31Another approved protocol, justified in §3 ScopeElsewhereOther protocol
URS-031 critical alarms within 5 sFDS 7.2, p. 12Alarm list: high dissolved oxygen alarm (DO_HI) to be set at commissioning9.1-01 to -07; 9.1-04 has no expected valueGap
No requirementFDS 5.4, p. 9: antifoam dosingFoam probe installedNone yetDesign only

Rows from the fictional BR-204 matrix: 14 requirements in all. FDS is the functional design specification.

Nine of 14 requirements trace cleanly, and the time goes on the other five
Traced end to end: 9Tested in other approved protocols: 3Sources disagree: 1Gap: no value for a test: 1
14requirements
  • Traced end to end9
  • Tested in other approved protocols3
  • Sources disagree1
  • Gap: no value for a test1

Fictional example from this guide

Show the numbers
PartValue
Traced end to end9
Tested in other approved protocols3
Sources disagree1
Gap: no value for a test1

What Annex 11, FDA and PIC/S say about tracing requirements to tests

None of the texts in force calls for a document named "traceability matrix", and each one wants the links.

  • EU Annex 11, section 4.4: "User requirements should be traceable throughout the life-cycle."16 It applies to computerized systems.
  • EU Annex 15, section 3.2: the URS "should be a point of reference throughout the validation life cycle", and 3.3 has its requirements verified during design qualification.3
  • Draft EU Annex 11, sections 6.5 and 9.5: "Documented traceability between individual requirements, underlaying design specifications and corresponding qualification and validation test cases should be established and maintained", "e.g. by means of a requirements traceability matrix".8 It is still a draft.17
  • FDA, General Principles of Software Validation (2002, devices): a software requirements traceability analysis "should be conducted", and requirements should be "measurable or objectively verifiable".30
  • PIC/S PI 011-3, for computerized systems: inspectors look for evidence that qualification testing "has been linked with the relevant specification's acceptance criteria", and for "the traceability of actions, tests and the resolution of errors and deviations". Then: "If the firm has not got proper change and version controls over its system life-cycle and validation documents, then the validation status is suspect."10

Four ways a spreadsheet trace matrix falls out of step with its protocol

What happensWhat goes wrong in the matrix
A test is renumbered. Section 9.2 gains a step.Rows now point at the wrong test, and nothing shows it.
A source gets a revision. The URS goes to revision 4.The header still says revision 3, so links point at wording that has changed.
A matrix is copied from a sister unit's protocol.The other unit's clause numbers come along.
A cross-referenced protocol is reissued.A requirement "tested elsewhere" now points at a superseded document.

One cause sits behind all four: the protocol is edited as a controlled document, and the spreadsheet is edited from memory. A matrix that is an appendix of the protocol is approved and superseded with it. It also has to be traced to numbered test steps, because a requirement traced to "section 9.2" forces a full re-read of that section when anything moves.

06 · The arithmetic

Working out an OQ acceptance range on a ±0.3 °C requirement

In shortThe sums are short. A setpoint plus or minus the tolerance gives the expected reading. The test limits come from the range. The design and the reference instrument both have to be good enough for the new tolerance. In the example, tightening control moves three numbers and leaves others standing.

CheckRevision 3Revision 4What it decides
Reading at the 37.0 °C setpoint37.0 ± 0.5 = 36.5–37.5 °C37.0 ± 0.3 = 36.7–37.3 °CTest 9.2-02 must change
Difference from the referenceWithin ±0.5 °CWithin ±0.3 °CTest 9.2-03 must change
Setpoints at the limits30.0 and 40.0 °C28.0 and 40.0 °CTest 9.2-04 must change
Controller range in the design spec25.0–45.0 °C covers it25.0–45.0 °C still covers itNo design change needed
Controller accuracy±0.2 °C within ±0.5 °C±0.2 °C within ±0.3 °CHolds, with less margin
Reference thermometer, ±0.05 °C0.5 ÷ 0.05 = 10:10.3 ÷ 0.05 = 6:1Still usable, if your procedure accepts 6:1
The fill step400 ± 10 L400 ± 10 LTest 9.2-01 stands
Tightening control narrows the pass window to 0.6 °C while the controller and thermometer stay as they were

Width of each band in °C, from the plus-or-minus figures in the table above

Revision 3Revision 4
Pass window at the setpoint1 °C0.6 °C
Controller accuracy band0.4 °C0.4 °C
Reference thermometer band0.1 °C0.1 °C

Fictional example from this guide

Show the numbers
Revision 3Revision 4
Pass window at the setpoint1 °C0.6 °C
Controller accuracy band0.4 °C0.4 °C
Reference thermometer band0.1 °C0.1 °C

Annex 15 asks OQ to include tests "to confirm upper and lower operating limits, and /or 'worst case' conditions", which is why a new low end of 28.0 °C changes a test step even though the everyday setpoint is unchanged.3 The thermometer row's accuracy ratio is the tolerance divided by the reference instrument's accuracy: how much finer the instrument is than what it checks. The ratio has no fixed value in the texts this guide cites. Your calibration procedure sets the ratio you accept, so a protocol should state it and name the certificate.

Three smaller sums that catch test steps out

  • Calibration due dates against the run date. The example's portable oxygen meter is due November 20. If tests 9.4-01 to -03 run after that date, they need a newer certificate. The date goes in the plan.
  • Resolution against tolerance. The example's drive speed displays to 1 rpm against a ±2 rpm tolerance. Round to what the instrument can show, and say so.
  • Counting coverage. Fourteen requirements, three proved elsewhere, 31 unique test steps. One step can serve two requirements, as 9.2-01 does, so count steps once, and show the sum.
07 · When a source changes

Change impact assessment after a URS revision: how to find the tests it rewrites, and what still holds

In shortEU Annex 15 expects a planned change to be assessed for its effect on documentation, validation and calibration. Compare the new revision with the one each document used, list the linked tests, mark the affected ones and write down what still holds. Approved documents get a new version and are never edited in place.

One changed requirement among 14 comes down to three of 31 test steps to rewrite
Test steps in the protocol31
Linked to the changed requirement4
Must be rewritten3

Fictional example from this guide

Show the numbers
StageTest steps
Test steps in the protocol31
Linked to the changed requirement4
Must be rewritten3

Annex 15 says any planned change that may affect quality "should be formally documented and the impact on the validated status or control strategy assessed". Section 11.4 has quality risk management evaluate a change for its effect on "documentation, validation, regulatory status, calibration, maintenance", to plan "any necessary process validation, verification or requalification efforts".3

PIC/S's 2007 recommendation calls commitment to change control "essential to ensure a continued validation status".31 Annex 11 puts the record in the file: validation documents "should include change control records (if applicable) and reports on any deviations".16 FDA's guidance says the qualification plan should include "the firm's requirements for the evaluation of changes".9

Five steps from a new revision to an approved new version of the protocol

  1. Compare line by line, against the revision each open and approved document was drafted from. Those may differ.
  2. List every linked test case, from the trace down to numbered steps.
  3. Mark what must change and say what still holds. The second list matters as much. It is the evidence that you looked: the design range, the reference instrument and the unaffected step.
  4. Redraft in a new version. An approved document stays as it was.
  5. Review and approve again. If the protocol has already run, the question moves to requalification, whether to test the machine again, and any change during execution is a deviation under Annex 15, section 2.7.3

Six source changes in two weeks at the example's plant, and what each one touched

Date, 2026ChangeWhat it touchesOutcome
Oct 6URS revision 4 for the bioreactor: temperature range and control3 test cases in an open OQRewrite
Oct 5Design spec revision B: agitator limited to 140 rpm at 400 L (revision A: 150 rpm)1 value, now disagreeing with the URSAuthor decides
Oct 3Filling line URS revision 4: wording clarified, values unchanged2 values re-checked in a PQNo impact
Oct 2Autoclave controller firmware 3.4 to 3.5, under change controlThe software version test in an OQ reportAccepted
Sep 30Oxygen meter calibration due November 20Tests 9.4-01 to -03 if run after that dateWatch
Sep 26Drawing revision 5: a drain valve tag renamedA tag reference in an approved IQ reportAccepted

Sample data. Real sites can count their own from the change control log. We found no public figure for how many source changes a validation team traces a year.

08 · Gaps and disagreements

Specs that disagree and values nobody wrote down: 150 rpm against 140, and an alarm set at commissioning

In shortThree kinds of row stop a protocol: a disagreement between two approved documents, a gap where a test has no value, and a design feature with no requirement. Each needs a named person to decide and a written reason. Software can find them. Picking the answer stays with people.

The requirement asks for 150 rpm, and the design limit and factory test both stop near 140

Agitator speed: URS-022's upper limit against the supplier's drive limit at 400 L and its factory test

URS-022, upper limit asked for150 rpm
Factory test, measured at the drive limit140.4 rpm
Design spec clause 6.3, drive limit140 rpm

Fictional example from this guide

Show the numbers
ItemValue
URS-022, upper limit asked for150 rpm
Factory test, measured at the drive limit140.4 rpm
Design spec clause 6.3, drive limit140 rpm
The rowThe exampleThe choicesWhat to record
DisagreementURS-022 asks for 20–150 rpm. The design spec limits the drive to 140 rpm at 400 L to stay within shaft torque. The factory test measured 140.4 rpm.Accept the limit and change the URS under change control, or ask the supplier to meet 150 rpm.Who decided, why, and whether the process needs 150 rpm at full volume
GapURS-031 wants alarms within 5 s. The alarm table leaves the high dissolved oxygen setpoint "to be set at commissioning", so test 9.1-04 has no expected result.Get the commissioned value, or take the sister unit's value and mark it to verify before the test runs, or type a value with a reason.The source, who verifies and when. Another unit's value is a suggestion until checked.
Design with no requirementThe design spec includes antifoam dosing with a pump and foam probe. The URS does not ask for foam control.Add the requirement and test it, or record that the site does not rely on the function.Whether the batch relies on it. Under draft Annex 11, a test with no requirement behind it would not count.8
A test at the equipment limit leaves the requirement open. Testing at 140 rpm proves the machine runs at 140 rpm, and it says nothing about a requirement for 150 rpm. Annex 15 has the URS as the point of reference, so a limit that falls short of it needs a recorded decision and, where the requirement itself changes, a change to the URS itself.3 The approver should see which of these happened.

Supplier documents have their own rules. Annex 15 lets tests done at the factory stand in for tests on site "where appropriate and justified" and "if it can be shown that the functionality is not affected by the transport and installation". It says the site's people should "confirm suitability and compliance with internal procedures before approval" of a third party's protocols.3

FDA's 2011 guidance leaves the last word with the firm's quality control unit, as section 4 quotes.9 Buying good instruments settles nothing by itself: FDA told one animal drug maker that "merely purchasing measurement instruments does not constitute equipment qualification".32

Borrowing a value from a sister unit has similar logic. Annex 15 allows data from outside a manufacturer's own program "provided that this approach has been justified" with adequate assurance about how it was obtained.3 That clause concerns supporting data, and a site's own procedure should say whether and how a sister unit's setpoint may be used. In practice, the safest form is the one the example shows: named source, named verifier, verified on the panel before the test runs.

09 · What inspectors cite

Form 483 counts and warning letters on equipment qualification and process validation files

In shortA Form 483 lists inspection observations that, in the investigator's judgment, may violate FDA's requirements.33 FDA publishes how often it cites each rule. In fiscal 2025 the device process validation section drew 153 citations and the drug equipment sections drew hundreds. Recent letters to drug makers show document faults in plain view: a qualification protocol that left out the machine in use, a qualification with no comprehensive range of operating parameters, and qualification documents completed after inspectors asked for them.

Process validation is the sixth most cited section on device 483s in FDA's last full year under the old rule

Fiscal 2025 citations by section, our sums of FDA's rows

820.100 corrective and preventive action342
820.30 design controls315
820.198 complaint files286
820.50 purchasing controls190
820.70 production and process controls155
820.75 process validation153
820.90 nonconforming product132

Source 33

Show the numbers
ItemValue
820.100 corrective and preventive action342
820.30 design controls315
820.198 complaint files286
820.50 purchasing controls190
820.70 production and process controls155
820.75 process validation153
820.90 nonconforming product132
On drug 483s, equipment and computer controls together reach 438 citations

Fiscal 2025 citations: the eight largest sections plus 211.63, our sums of FDA's rows. Highlighted: equipment and its records.

211.22 quality control unit309
211.192 production record review236
211.67 equipment cleaning and maintenance204
211.100 written procedures, deviations201
211.160 laboratory controls176
211.84 testing of components161
211.68 automatic and electronic equipment153
211.113 microbiological control129
211.63 equipment design, size and location81

Source 33

Show the numbers
ItemValue
211.22 quality control unit309
211.192 production record review236
211.67 equipment cleaning and maintenance204
211.100 written procedures, deviations201
211.160 laboratory controls176
211.84 testing of components161
211.68 automatic and electronic equipment153
211.113 microbiological control129
211.63 equipment design, size and location81
Device process validation and drug equipment design citations both climbed back after the pandemic dip

Single rows in FDA's spreadsheets by fiscal year. The dip spans the COVID-19 pandemic.

820.75(a) lack of or inadequate process validation211.63 equipment design, size and location
0501001509381
FY18FY19FY20FY21FY22FY23FY24FY25

Source 33

Show the numbers
820.75(a) lack of or inadequate process validation211.63 equipment design, size and location
FY1813853
FY1912066
FY204944
FY212425
FY228660
FY237974
FY248585
FY259381

Read these with FDA's own caveats. Not every Form 483 is in the data, since some are manually prepared. A 483 lists observations and can carry several: 2,837 drug citations sit on 713 forms and 2,660 device citations on 791 in fiscal 2025.33 The rows name a rule and a short description, so they cannot say how many concern a protocol. The 820.75 rows count the old rule's last full year. Inspections under the QMSR read ISO 13485 instead.12,13

Seven warning letters to drug makers, and the document fault inside each one

LetterWhat FDA wroteThe document fault
736888, September 2, 2026, over-the-counter drug makerA qualification protocol and report "lacked total organic carbon (TOC) testing, conductivity, or microbial content" to show the system was "fit for its intended use".34A plan that left out the tests its use depends on
728604, June 12, 2026, animal drug maker"You failed to provide a comprehensive qualification protocol", and buying instruments did not fill the gap.32Equipment bought, with no plan behind it
718601, January 7, 2026, drug makerAn "executed metal detector qualification protocol did not include the qualification of the metal detector MFG-1276", which inspectors found not working.35A file that misses the machine in use
711191, September 23, 2025, drug maker"Process validations for both drug products were last executed in 1999", despite later formula changes.36Changes that never reached the validation file
704786, June 12, 2025, drug makerInvestigators saw the "quality assurance manager generating and completing equipment qualification documents investigators previously requested".37A record written after someone asked for it
700242, April 16, 2025, active ingredient makerOne passage says a qualification "lacked a comprehensive range of operating parameters". Another says a qualification lacked "evaluation of operating conditions for different flow rates or product throughput".38Limits not proved
610444, March 10, 2021, drug makerThe firm "did not have installation qualification and operation qualification documentation for your manufacturing equipment".6No qualification record at all

Each letter also carries other findings. A warning letter records FDA's view of one firm at one time, and we cite each only for what it says.

Why qualification documents go wrong: eight common causes

The errorWhy it happensWhat catches it
A value copied wrong, or into the wrong fieldLong retyping across six documentsA check against the source page, value by value
A value from a superseded revisionA local copy from last quarterOne current-revision list, checked at draft time and again at approval
A requirement with no testThe matrix was built after the protocolBuilding the trace first
A test with an impossible rangeLimits retyped by hand with nothing to test them, for instance columns swappedA simple rule: lower must be below upper, inside the design range
Limits never challengedThe template's default setpoint stayed inA review question: which test proves each limit?
An instrument out of calibration on the run dateThe due date sits on a certificate no one rereadsDue date against planned run date
A protocol copied from a sister unitSpeed: the structure is right and the clause numbers are notRebuilding the references from this unit's records
A change that never reaches the fileNo link from the change record to the testsRequirement-to-test links read at each change

Our analysis, from the rules and letters above and the example. No public study ranks these causes by frequency.

10 · What a wrong number risks

What a wrong number in a protocol puts at risk: copying error rates, failed runs and late equipment

In shortNobody has published a copying error rate for qualification protocols. Studies of single-entry typing in other settings run from about 3 in 1,000 to 37 in 1,000 values. A wrong value becomes an expected result nobody can meet, or a test that passes against the wrong limit. The first costs days and the second is worse, because it stays hidden.

How often people mistype data depends heavily on how they do it

Error rates in clinical data and glucose records. Neither study measures a validation engineer.

Medical record abstraction, copying from charts (pooled)6.57%
Manual glucose entry, outpatient clinics3.7%
Optical scanning (pooled)0.74%
Single data entry (pooled)0.29%
Double data entry (pooled)0.14%

Source 39,40

Show the numbers
ItemValue
Medical record abstraction, copying from charts (pooled)6.57%
Manual glucose entry, outpatient clinics3.7%
Optical scanning (pooled)0.74%
Single data entry (pooled)0.29%
Double data entry (pooled)0.14%

One study compared 6,930 manually entered glucose results with the instrument's own result: 260 differed (3.7%), and 37 of those differed by more than 20%.39 A meta-analysis of 93 papers published from 1978 to 2008 pooled single data entry at 0.29% and double entry at 0.14%.40 Those are other settings, used here only as a bracket.

Applying that bracket to a site writing 40 protocols a year

StepLow endHigh end
Values per protocol (the example)1919
Protocols a year (illustrative)4040
Values copied a year760760
Error rate borrowed from other settings0.29%3.7%
Wrong values to catch a yearabout 2about 28

Illustrative, and likely low in value count: a real OQ can quote many more than 19 values. Your own number comes from review comments and deviations whose cause was a wrong expected result.

What a late or wrong qualification document costs, by when it surfaces

When it surfacesWhat happensWho feels it
At the deskAn edit, a re-checkThe author, for minutes
In reviewA comment cycle, sometimes a re-issueAuthor and reviewer, for days of waiting
During executionA deviation under Annex 15 2.7 or 2.8, with an investigation and an impact statement in the report3Validation and QA, and the equipment stays occupied
Never, until an inspectionA test passed against a limit that does not prove the requirement. A Form 483 observation or worse, and questions about product made sinceThe site, and patients if a parameter mattered

Queue time is the cost that seldom reaches a budget line. Equipment waits for its protocol, a protocol waits for a reviewer, and a project waits for release to the next stage under Annex 15, section 2.10.3 Nothing public measures that delay for qualification. A week of delay on one machine can matter more than the engineer's hours, and only your project plan can price it. Part C shows how to find your own figure.

11 · Digital validation and the market

Paperless validation reached 58% of organizations in one vendor's survey, while protocol hours stay unmeasured

In shortOne validation software vendor's surveys are the main public numbers. Digital validation systems jumped from 30% to 58% of organizations surveyed in a year, and most respondents report rising workloads. Market size and hours per protocol have no measured public figure, so treat any you see with care.

More than half of the organizations in one vendor's survey now run a digital validation system
58 in 100

organizations use a digital validation system in the 2025 survey, up from 30 the year before. Vendor survey, over 300 professionals.

Source 41

Show the numbers
MeasureValue
organizations use a digital validation system in the 2025 survey, up from 30 the year before. Vendor survey, over 300 professionals.58 of 100
Most respondents keep reporting more work than the year before

Respondents reporting a higher workload. Vendor survey; 2023 not given on the page we read.

81%2022
61%2024
66%2025

Source 42,41

Show the numbers
PeriodValue
202281%
202461%
202566%

The same vendor's 2024 survey has 60% of respondents saying validation consumes "8% to 10% or more of their project budgets", and 48% organizing validation site by site.42 Its 2025 report has 16% using AI in validation and 46% with no current plans.41 The 2026 report, as sponsored content, has 614 respondents, 39% "already using or evaluating AI for validation" and 78% confident it will be standard by 2030.43

These come from a firm that sells digital validation, so read them as direction and allow for who answered. The 16% and the 39% ask different questions and do not make a trend.

What paperless validation changes, and the part it leaves with the author

A digital validation system generally replaces paper in execution: electronic test steps, captured results, routed approvals, and a trace generated from links people enter. That removes wet signatures and missing pages. A value still has to reach the system from a PDF, and a person usually types it.

Drafting from source records and redrafting after a change are a separate job, and a site can buy one, the other or both. On the vendor pages we read, most AI claims about protocol generation carry no method, so this guide quotes none of them.

Protocol hours, copy errors, failed runs, market size: what to measure yourself

What you might wantWhat we foundWhat to measure instead
Hours to write a protocol, by typeNo measured figure. Vendor pages quote estimates, and one we read says no representative study exists44First-saved to approved dates in your document system, plus a time log on three protocols
Copying error rate in protocolsNo public figure; other settings only39,40Review comments and deviations caused by a wrong value
Failed executions due to a documentNo public figureYour deviation log, by root cause
Market size for validation softwareNo primary source; trade estimates with no methodYour own spend on validation staff and consultants
Scale of inspection1,248 FDA drug quality assurance inspections in fiscal 202545Your own inspection history on qualification
12 · AI and its limits

Can AI draft a qualification protocol? Draft Annex 22, FDA's letter on AI documents and the review duty

In shortNo text in force that we read forbids a drafting aid, and none approves one. Draft EU Annex 22 says generative AI "should not be used" in critical GMP applications, and that qualified people answer for outputs elsewhere. FDA has told one firm it must review AI-generated documents. Whether a protocol draft is critical is your own documented assessment.

Automate what is checkable against a page; keep the calls that have no page

Tasks in writing a protocol, placed by our judgment

Judgment the task needs →
Keep with people
Software drafts, people decide
Low priority
Automate, check
Copying valuesFinding revisionsComparing revisionsDrafting test stepsAcceptance criteriaCritical parameters
How easily a person can check the output →

Our reading of the sources 3,22,46

Show the numbers
ItemHow easily a person can check the output (0–1)Judgment the task needs (0–1)
Copying values0.750.10
Finding revisions0.650.19
Comparing revisions0.720.28
Drafting test steps0.720.52
Acceptance criteria0.200.60
Critical parameters0.150.70
TextStatusWhat it saysWhat it means for drafting
Draft EU Annex 22, section 1Draft. EudraLex Volume 4 lists no Annex 22 on November 3, 202617,22Generative AI and large language models (LLMs) "should not be used in critical GMP applications". In non-critical uses, "personnel with adequate qualification and training should always be responsible for ensuring that the outputs ... are suitable for the intended use".If this stands, you assess whether your use has "direct impact on patient safety, product quality or data integrity", and document it.
EMA workshop report, EMA/156789/2026Workshop of June 30, 2026. No revised text published47Comments supported allowing LLMs in GMP applications. The drafting group "has therefore discussed" widening the scope under a fully documented, risk-based control strategy, and concerns remain.The wording may move. Inspectors' target for final text is Q4 2026, with no adoption date.18
FDA warning letter 722591April 2, 2026. One firm, with other findings46"If you use AI as an aid in document creation, you must review the AI generated documents to ensure they were accurate and actually compliant with CGMP", under 21 CFR 211.22(c). CGMP means current good manufacturing practice.No statement of general policy, and a clear signal about who answers for the result.
FDA draft guidance on AIDraft, January 202548Does not address AI "used for operational efficiencies (e.g., internal workflows, resource allocation, drafting/writing a regulatory submission)" that do not affect patient safety, drug quality or study reliability.Aimed at AI behind regulatory decisions. A protocol-drafting aid is more plainly a CGMP question under Part 211.
EMA reflection paper, 2.3.6Adopted September 9, 202449Manufacturing AI should follow quality risk management and ICH Q8, Q9 and Q10, "awaiting revision of current regulatory requirements and GMP standards".Risk management is the frame today. EMA and FDA also set shared principles on January 14, 2026.50
ISPE GAMP AI guideJuly 2025, industry guide51Developing and using AI-enabled computerized systems in GxP areas, the regulated "good practice" fields such as manufacturing, laboratory and clinical work. It is sold, and we read its publisher's page.A shared vocabulary for your assessment, with no force of law.
EU AI Act, after the AI OmnibusIn force July 27, 2026; Annex III rules December 2, 2027; Annex I rules August 2, 202852Timing for high-risk categories.A separate legal question from GMP. Ask counsel where a tool sits.

Where AI drafting goes wrong in a protocol, and why a reviewer may miss it

A model can state a value that appears in no source, called a hallucination, or leave one out. One company's own study on generating clinical notes reports a 1.47% hallucination rate and a 3.45% omission rate across 12,999 annotated sentences. All its authors worked for that company, the setting differs, and it reports the rates falling as prompts and workflows improved.53 It shows why every value needs a page a reviewer can open.

The second risk sits with the reader. Automation bias is the tendency to over-rely on automated output. A systematic review drew 74 papers from 13,821 retrieved and found that workload, task complexity and time pressure feed it, and that training and emphasizing the user's accountability reduce it.54 A clean draft reads as correct. A site that replaces four days of copying with ten minutes of skimming has lost the checking it used to get by accident.

Controls that make an AI draft reviewable in a GMP file

  • No value without a source page, so an unread or missing value stays empty and flagged.
  • Locked wording stays locked. Approved template text changes only through its own change control.
  • Superseded revisions are never a source, and the revision used is recorded per section.
  • Only a person clears a flag, accepts a draft or signs, with name, date, time and meaning.27
  • Every step is on an audit trail, in line with 21 CFR 11.10(e) and the ALCOA+ data integrity principles the UK regulator MHRA describes: attributable, legible, contemporaneous, original, accurate, plus complete, consistent, enduring and available.26,55
  • Your own intended-use and risk assessment of the tool, and your validation of your use of it. A tool used in a GMP activity is a computerized system, and that work stays with the regulated company.16,22
  • Reviewer measures. Seed known errors in a pilot draft and count what reviewers catch.
13 · How teams do it today

Four days on one OQ by hand: what the author, reviewer, QA and supplier each do to a protocol today

In shortA validation engineer writes, an automation or process engineer checks the content, QA approves, and a validation lead owns the templates. By hand, the example's OQ takes four working days, and only one of them is test design. Teams work from Word and spreadsheets, a digital validation system, consultants, or a mix.

Typical roles
VE

Validation engineer

Writes protocols and reports, usually several at once, from a queue set by project dates.

Cares about: more hours on test design and fewer on transcription.
AE

Automation or process engineer

Reviews test content, knows what the machine does, confirms commissioned values on the panel.

Cares about: being told which tests changed.
QA

QA approver

Approves requirement revisions and protocols before execution, and answers to inspectors for both.

Cares about: seeing every requirement traced before signing.
VL

Validation lead

Owns the master plan and locked templates, sets the rules, and watches the queue.

Cares about: templates changing only through change control.
SP

Supplier or commissioning contractor

Supplies the design spec and factory test report, and sometimes drafts protocols that the site must confirm under Annex 15, section 2.6.3

Cares about: handover dates, and acceptance of the factory results.
Five stages separate a requirement from an approved protocol, and each hand-off can send it back
  1. 1Queue and template

    The lead assigns the unit. The author picks the approved template.

    Validation lead to engineerAt the start
  2. 2Gather sources

    Check each record is the current approved revision.

    Engineer, document controlHalf a day
  3. 3Copy and write

    Setpoints, tags, dates, test steps, expected results.

    Engineer, supplier for questions2.5 days
  4. 4Trace and chase

    Build the matrix. Chase missing and disagreeing values.

    Engineer, automation engineer1 day
  5. 5Review and approve

    Content review, then quality approval.

    Automation engineer to QAWaiting time varies

Fictional example from this guide

Show the numbers
StepWhat happensWhoTime
Queue and templateThe lead assigns the unit. The author picks the approved template.Validation lead to engineerAt the start
Gather sourcesCheck each record is the current approved revision.Engineer, document controlHalf a day
Copy and writeSetpoints, tags, dates, test steps, expected results.Engineer, supplier for questions2.5 days
Trace and chaseBuild the matrix. Chase missing and disagreeing values.Engineer, automation engineer1 day
Review and approveContent review, then quality approval.Automation engineer to QAWaiting time varies
Only one of the four days goes on test design

One OQ protocol by hand, working days by task. The example's estimate; no measured public benchmark.

Finding revisionsCopying valuesWriting testsBuilding the traceChasing values
By hand, 4.0 days0.51.510.50.5

Fictional example from this guide

Show the numbers
Finding revisionsCopying valuesWriting testsBuilding the traceChasing values
By hand, 4.0 days0.51.510.50.5

Word templates, a validation system, outside drafters or drafting software: who writes the protocol, and where each strains

HowWhere it worksWhere it strains
Word templates and spreadsheetsLow volume, a stable team, no new systems to validateThe trace drifts, and each change means a re-read
A digital validation systemExecution, approvals, and trace links from data entered into itValues are still found and typed, and templates need building in the system
Consultants or the supplier draftingPeaks, new plants, specialist equipmentKnowledge leaves with them, and the site must still confirm suitability before approval3
Drafting software over your recordsHigh volume, frequent changes, values spread across PDFsNeeds clean records and your own assessment of the tool. A newer practice, with few public results
Part B · See it working

Botminds Validation Document Automation on a 500 liter bioreactor: a new URS revision at 9:02 am, three signatures by 10:05

Part A described the work without naming a product. This part shows how Botminds does it on the bioreactor in the example at the top of the page. Every person, plant, document and figure on these screens is sample data. The software drafts and people approve. You qualify your own equipment and you validate your use of this software. It is never validated, compliant or certified on your behalf.

14 · One protocol, one change

A 28.0 °C requirement reaches three test cases: the OQ-BR204-001 redraft, step by step

In shortLena Ortiz, the validation engineer, starts from the trace matrix. It shows one gap and one disagreement before she reads the protocol. A new URS revision arrives at 9:02 am. Three test cases are marked, the section is redrafted citing the new page, and she accepts it and sends version 0.2 to her reviewer.

The example's morning: one new revision to a released protocol in about an hour
  1. 9:02 amURS revision 4 arrives

    Approved by Dr. Maya Chen under change control CC-26-142.

  2. 9:18 amLena Ortiz signs as author

    After the redraft and her two decisions.

  3. 9:41 amOmar Haddad signs as reviewer

    Meaning: test content and commissioning values checked.

  4. 10:05 amDr. Maya Chen approves

    Meaning: approved for execution. Version 1.0 is released.

Fictional example from this guide

Show the numbers
WhenWhat
9:02 amURS revision 4 arrives
9:18 amLena Ortiz signs as author
9:41 amOmar Haddad signs as reviewer
10:05 amDr. Maya Chen approves
1

The trace matrix comes before a word of the protocol

Every requirement in URS-BR204 runs across to its functional spec clause, its design record and the test cases that prove it: 14 requirements and 31 test steps. Nine are traced end to end, three are tested in their own approved protocols, one needs a decision and one is a gap. Each cell is a link with its evidence.

The trace matrix. The banner reports the new revision. On the right, URS-031: the alarm table leaves DO_HI, the high dissolved oxygen alarm, "to be set at commissioning", so test 9.1-04 cannot state its expected result.
2

The requirement says 150 rpm and the design spec says 140

The consistency checker marks URS-022. The design spec's clause 6.3, on page 15, limits the drive to 140 rpm at the 400 L working volume because of shaft torque. The test runs at the equipment limit until Lena decides: keep 140 rpm, or ask for a URS change. As Part A says, keeping the limit should come with a recorded reason, and a true change belongs in the URS.

Specs that disagree. Both documents are approved. The screen shows the clause, the full chain and the two choices.
3

"Show what it changes": three test cases turn amber and one stands

Revision 3 and revision 4 sit side by side. Test 9.2-02 expects 36.5–37.5 °C where revision 4 needs 36.7–37.3 °C. Test 9.2-03 accepts ±0.5 °C. Test 9.2-04 tests 30.0 °C and misses the new 28.0 °C low end. Test 9.2-01, the fill step, is not affected. The panel also lists what still holds: the controller's 25.0–45.0 °C range and ±0.2 °C accuracy, and thermometer TR-07 at 6:1.

What the change touches. The checker marks and never clears a mark, and it never edits an approved document.
4

Section 9.2 redrafted, with the old wording struck through

Lena clicks "Draft the updated section 9.2". The section writer reads page 4 of revision 4, rewrites the three test cases in the locked template's wording, and shows old and new expected results together. Temperature probe TT-204-01 now reads 36.7–37.3 °C, and steps 2 and 3 repeat at 28.0 and 40.0 °C within ±0.3 °C.

The redraft. Nothing takes effect until the author accepts.
5

She accepts, and the matrix moves to revision 4

The header reads URS-BR204 rev 4, the protocol moves to version 0.2, and URS-021 shows "Traced · rev 4" with its four tests green. The protocol goes to Omar Haddad, the automation engineer, and the step goes on the activity record.

Traced to the new revision. Test 9.2-04 now repeats its steps at 28.0 and 40.0 °C. The agitation row still shows that the specs disagree, because that is a separate decision.
15 · Inside the protocol

From a locked template to a signed OQ protocol: 19 sections drafted, 19 values cited, one still missing

In shortThe protocol moves through four steps on screen: Template, Review, Validate and Output. The author ticks sections and gives instructions in plain English. Software drafts and checks. She decides the missing value and the disagreement, and export waits until she has. Three people then sign, each with a stated meaning.

The screen's step called "Validate" is the author checking values against their sources, and its status reads "Validating" while she does. It is a name for that step. Qualification and validation remain work your own people do and sign.
1

The right template and the current records for BR-204

Templates are approved and locked. The source finder lists six records for this unit, current approved revisions only, with pages and dates. The sample shows the view before revision 4 was accepted.

Pick a template. Version 4.2 of the process equipment OQ has 21 sections. The records add up to 157 pages.
2

Plain English in, locked wording untouched

Lena ticks 19 of the 21 sections. Clean-in-place is marked as having its own protocol, and foam control is suggested because the design spec lists a pump and probe the requirements do not. The run on the right reads six records, drafts the ticked sections, extracts 19 values and builds the trace. The sample reports a draft ready in 52 seconds.

Drafting the sections. Each value in section 9.2 carries its citation, here URS-021 rev 4, page 4. The last step ends amber: one value missing, one where sources disagree.
3

Every value beside its source page

All 19 values are listed with the document and page: 17 matched, one to check and one missing. Clicking a value opens the page with the passage marked. A reviewer opens the same page to check the number.

Every value and its source. The page on the right is the sample's URS, which is fictional. "1 missing, export waits for it" sits at the foot.
4

The missing alarm setpoint stays empty until a person decides

Page 12 of the design spec shows why no source holds it: DO_HI is "to be set at commissioning". The closest match is the sister unit's approved alarm list, at 60% air saturation. Lena can use it and mark it for verification, ask Omar Haddad, or type a value with a reason. In the story she takes 60%, marked for Omar to confirm on panel HMI-204 before test 9.1-04 runs. Another unit's value is only a suggestion until that happens.

A value no source holds. Three choices, each recorded with who and why.
5

The controlled template, with both trace appendices

The protocol is written into the plant's controlled Word template, 38 pages, with Appendix A (requirement to test) and Appendix B (value to source). Blank results tables are ready for execution. Every page carries a draft watermark, marked not for execution, until QA signs. The sample's scope paragraph names foam control, although section 9.10 was only suggested at this point: a reviewer's catch.

The output. Word or PDF/A, the archival form of PDF, with the purpose paragraph now citing URS revision 4.
6

Three signatures, each with its meaning

Lena signs as author at 9:18 am. Omar signs at 9:41 am with the meaning "Reviewed — test content and commissioning values checked". Dr. Maya Chen re-enters her password and approves "for execution" at 10:05 am, and version 1.0 is released. Each signature shows name, date, time and meaning, the elements 21 CFR 11.50 asks an electronic signature to show.27 On screen the controls read "designed to support 21 CFR Part 11 and EU Annex 11", which is the accurate wording: your validation of your own use decides the rest.

Three signatures. Approved protocol, version 1.0. Execution comes next, and it stays with your people.
The approval dialog. It states the document version and the meaning before the password.
16 · The other screens

Source changes, every open protocol, locked templates, the dashboard and the rules QA sets

In shortAround the single protocol sit the screens a validation lead works in: what changed in the last two weeks, what is open at each site, the approved templates, where values came from, and the settings that hold your own rules.

Design with no requirement. Antifoam dosing is in the design spec and missing from the URS. The panel suggests a test, and the next URS revision should say whether the batch relies on it.
Further down the matrix. Test 9.1-04 is red. Audit trail, log-ins and restart have tests of their own, and batch backup points to another approved protocol.
Source changes. The six revisions from section 7, each with what changed and what it touches. Approved documents are never edited in place: a change opens a new version.
Every open protocol and report. Sample equipment at two plants, including a filling line, autoclave, freeze dryer, ultrasonic welder and pouch sealer, so one team can run drug and device-style work in one list.
Approved templates. Nine in the sample, each with a version, owner and approval date. Wording changes only through change control, with the template owner.
The dashboard, on sample data. The by-hand bars are the sample's 2025 document log with an 8-hour day, and the current times are sample figures. Of the 23 flags, 11 are values not found in any source.
Approvers and rules. One default deserves a look when you configure it: "Prefer the equipment limit" lets design limits win over requirements with the author's confirmation. Decide whether your QA wants a URS change each time.
When a source changes. Mark linked tests, draft the update, open a new version, and choose who hears about it.
17 · Who drafts, who signs, results

Who drafts a protocol and who signs it: six agents, three people and what one medtech result says

In shortEach agent has one job and a limit it cannot cross. Only people accept a draft, clear a flag or sign. Sources go in, and a controlled document, a trace matrix and a value-to-source record come out. The one customer result is stated exactly as published, and every other figure is sample or target.

From source finder to change impact checker: what each agent does to a protocol, and where it stops

AgentIts jobIts limit
Source finderFinds current, approved records for the equipment and indexes each page.Never uses a superseded revision as a source. Another unit's records appear only as a flagged suggestion.
Value extractorPulls setpoints, ranges, tolerances, tags and dates, with the unit as written and the page and passage.Never fills an unreadable value. It says so.
Section writerDrafts each ticked section, and redrafts when a source changes.Never changes locked wording. A value with no source page stays empty and flagged.
Consistency checkerCompares each value with every source that mentions it: missing, disagreeing, out of range, wrong unit.Never clears a flag.
Trace-matrix builderLinks requirement to clause, design record and test case, and builds both appendices.A requirement is covered by a test or a justification, and anything else is reported as a gap.
Change impact checkerCompares a new revision with the one each document used, marks linked tests and lists what still holds.Never edits an approved document, and never clears a mark.

A formatting step then writes the controlled template and PDF/A, and it keeps the draft watermark on until QA signs.

Fictional, from the sample data
LO

Lena Ortiz · validation engineer, author

Accepts each draft, clears each flag and signs first.

"I spend three days copying setpoints and ten minutes thinking about the test."
OH

Omar Haddad · automation engineer, reviewer

Checks the test content and the commissioned value on the panel, and signs second.

"Tell me which tests changed."
MC

Dr. Maya Chen · Head of Quality Assurance, approver

Approves URS revisions and protocols for execution, separate from the people who wrote them.

"If I can't trace it, I can't sign it."
DO

Dana Okafor · validation lead, template owner

Owns the locked templates and the rules.

"The template changes through change control and nowhere else."

The author, reviewer and approver are three people in the sample. The settings choose who holds each role, so your procedure should keep them apart.

What goes in and what comes back: a protocol in your Word template with two trace appendices

Read from your systems

  • User requirements, every approved revision
  • Functional and design specs, alarm lists, factory test reports
  • Drawings and approved IQ reports
  • Calibration certificates

From your team

  • Approved templates for IQ, OQ, PQ, reports and the master plan
  • Plain-English instructions per protocol
  • Rules for values and approvers
Agents find, draft and trace Every value points to its page
The engineer decides
QA signs

What comes out

  • The protocol or report in your controlled Word template, and PDF/A
  • Appendix A: requirement to test
  • Appendix B: value to source, with document, page and passage
  • Tests to rewrite when a source changes
  • The activity record of every step

It works with what qualification already runs on: your document system sends new revisions and closed change controls in, and Word and PDF/A go back. Execution can stay in the digital validation system or on the paper you use today.

What the 40-minute target, the 0.6-day estimate and the customer result each measure

The estimate: one OQ protocol from 4.0 days by hand to 0.6 with the author's checks

Working days per task. The solution's own estimate on sample data, including the author's decisions and chasing.

By handWith the solution
Finding the current revisions0.5 days0.05 days
Copying values1.5 days0.1 days
Writing test steps and results1 day0.2 days
Building and checking the trace0.5 days0.05 days
Chasing missing and disagreeing values0.5 days0.2 days

Fictional example from this guide

Show the numbers
By handWith the solution
Finding the current revisions0.5 days0.05 days
Copying values1.5 days0.1 days
Writing test steps and results1 day0.2 days
Building and checking the trace0.5 days0.05 days
Chasing missing and disagreeing values0.5 days0.2 days
FigureWhat it isWhat it measures
About 40 minutesDesign targetPer protocol, from template to a checked draft. By-hand baseline: 3 to 4 days, from an 8-hour day.
100% of requirements tracedDesign targetTo a test or a justification, before signing.
0.6 daysEstimate on sample dataThe whole authoring job, with the author's checks, decisions and chasing. Longer than 40 minutes because it counts more of the work.
52 seconds, 19 sectionsSample run on screenTime to a first draft of the sample protocol. Your own will differ.
100+ protocols, four weeks, 80%+Customer result, as publishedSee below.
The customer result, in the words Botminds publishes. "In production at a global medtech manufacturer: 100+ protocols live, four weeks from start, 80%+ automation." The 80%+ refers to the authoring work. That is everything we state about this customer's result. The customer validates: the product drafts, and the customer's people review and approve. Treat it as evidence that the approach can run in production, then test it on your own documents, since your templates and records will differ.

What stays yours: your assessment, your validation and your signatures

  • The tool's status under the rules. Drafting of this kind relies on generative AI. Draft Annex 22 would keep such models out of critical GMP applications and hold qualified people responsible elsewhere.22 Whether this use is critical at your site, and how you control it, is your documented assessment. Draft text may change.47
  • Your validation of your use of it. For a device maker this may fall under FDA's Computer Software Assurance guidance; for a drug maker, Annex 11 and 21 CFR 211.68.16,2,19 The platform carries controls that support your compliance: roles, maker-checker separation, signatures, the audit trail and export of it. Botminds is SOC 2 Type II audited, and its information security is managed to ISO 27001.
  • Reading what you sign. Citations make checking faster, and the checking is still yours. Plan for the reviewer risk described in section 12.
Part C · Are you ready to automate?

Automating IQ, OQ and PQ protocols at your own site: what copying costs, what it can return and how to test it

You run validation or site quality, or you are waiting on a machine to be released. This part is written for you: where the hours and the risk sit, how to put your own numbers on them, whether your records and procedures are ready, and what to ask any vendor of validation protocol software, including us.

18 · What it costs you

What hand-written protocols cost you: engineer days, re-reads after each change and deviations on the floor

In shortThe direct cost is engineer days, and you are already paying them. The bigger costs tend to sit in the queue in front of the validation desk, the re-reading after each change, and deviations caused by a wrong number. Each can be measured from records you already hold, in about a week.

153

citations under 21 CFR 820.75, device process validation, in fiscal 2025, by our sum of FDA's rows.33

FDA data
438

drug citations under 211.63, 211.67 and 211.68, equipment and its controls, in fiscal 2025, by our sum.33

FDA data
60%

of respondents said validation takes 8% to 10% or more of project budgets.42

Vendor survey, 2024
On an illustrative site, drafting is where most hours sit, and change tracing is easy to leave out of a budget

Hours a year at 40 protocols and 60 traced source changes. Replace every input in the calculator below.

By handWith drafting software
Writing protocols, 32 hours to 5 each1,280 hours200 hours
Tracing source changes, 6 hours to 1 each360 hours60 hours

Illustrative · replace with your own numbers

Show the numbers
By handWith drafting software
Writing protocols, 32 hours to 5 each1,280 hours200 hours
Tracing source changes, 6 hours to 1 each360 hours60 hours

A worked figure: O*NET reports a 2025 median wage of $49.25 an hour for industrial engineers, the related occupation it uses on its validation engineers page.56 Four 8-hour days is $1,576 in wages alone, before benefits and overhead. At 40 protocols a year that is 160 engineer days. The four-day figure is the example's own, from a sample log. No measured public benchmark exists, so use yours.

Protocol hours, re-reads, wrong values and queue days: where each hides and how to count it in a week

The costWhere it hidesHow to find your number in a week
Authoring hoursSpread across engineers, never booked to a machineFirst-saved to sent-for-review dates on your last 20 protocols, by type. Ask three authors to log one protocol by task.
Source changes tracedThe change control log, with no link to protocolsCount last year's revisions of URS, specs, drawings and certificates that reached an open or approved document.
Re-reading after a changeNobody records itTime your next three changes: how many documents were opened, and how many moved.
Review cyclesComments in Word, resolved and goneVersions before approval on your last 20, and the share of comments about a wrong value or reference.
Deviations caused by the documentRoot cause field in the deviation systemFilter qualification deviations by root cause, and price each one with investigator hours and days the machine sat idle.
The queueProject plans, as "validation pending"Days between mechanical completion and protocol approval on your last five machines. Ask the project lead what a week is worth.
Inspection exposureYour last inspection's questionsPick one machine and time how long it takes to show which test proves each requirement.

A test passed against the wrong limit, the engineer who knows why and other validation costs a spreadsheet misses

The test that passed against the wrong limitIt costs nothing until someone asks, and then it reaches the product made since.
The engineer who knows whyWhen the links live in one person's head, the file can be defended only on the days that person is in the building.
The test nobody had time to designHours spent copying come out of thinking about failure modes and worst cases, the part an inspector will argue with.
The reissued protocol at the wrong momentA change that lands while the machine is booked for execution can cost the slot as well as the edit.
19 · Your return

What automating protocol drafting returns on your yearly document count

In shortTwo levers can be counted directly: authoring hours and hours spent tracing changes. Three more depend on your records: fewer review cycles, fewer deviations caused by the document and a shorter queue. The calculator takes your numbers, and its defaults are illustrative.

Five places a qualification program gets time or risk back, each with its formula

The writing

Authoring hours per protocol

Finding, copying, drafting and building the trace, with your engineer checking the result.

protocols × (hours today − hours with checks) × hourly cost
The change

Hours to trace a source change

From reading whole protocols to reviewing marked tests.

changes × (hours today − hours after) × hourly cost
The review

Fewer cycles on wrong values

Reviewers open the cited page to check a value, so less of each round goes on hunting.

protocols × cycles avoided × hours per cycle × hourly cost
The floor

Deviations caught at the desk

Gaps and disagreements surface before execution.

document-caused deviations avoided × cost per deviation
The queue

Earlier release of equipment

Only worth counting if the validation desk is what holds the project.

days earlier × what a day of that project is worth to you

Your hours and dollars back across a year of IQ, OQ and PQ protocols

Your volume and rates
Illustrative yearly value
Hours on writing and tracing today0
Authoring hours saved0
Change-tracing hours saved0
Engineer days freed (8 hours)0
Time saved, valued$0
Net of yearly cost$0

Formulas: authoring hours saved = documents × (hours today − hours after). Tracing hours saved = changes × (hours per change today − hours after). Engineer days = hours saved ÷ 8. Value = hours saved × cost per hour. Net = value − yearly cost. Review cycles, deviations and queue time are left out, and so are hours spent on your first-year template loading and tool validation beyond the yearly cost. Savings only become cash if the freed hours go somewhere: fewer consultants, or a backlog cleared.

Saved hours must not come out of the risk assessment. ICH Q9(R1) is direct about it: "Resource constraints should not be used to justify the use of lower levels of formality in the quality risk management process."57 The saving here comes from copying and re-reading, which no regulation asks for.

A small site may find the net close to zero or negative, and that is a sound answer. At 10 documents a year, the same inputs save 570 hours and leave a net loss of about $48,700, so the case rests on the queue or the risk, or it waits.

20 · Readiness check

Is your qualification program ready to automate? Eight questions on records, templates and review

In shortScore each from 0 to 2. Drafting software reads what you have, so clean revisions, numbered requirements and locked templates matter more than budget.

1
Your yearly protocol count

Do you know how many IQ, OQ and PQ protocols and reports you issue a year, by site and type?

Why it mattersThe count is the multiplier in every sum, and a low one may not repay the effort.
A strong answer"Yes, from the document system, and a capital plan for the next two years."
2
Current revisions, findable

Can someone find the current approved URS, design spec, drawing and certificates for a machine in minutes?

Why it mattersSoftware can only cite what it can reach, and a wrong "current" poisons every value after it.
A strong answer"All in the document system with a status field, supplier documents included."
3
Requirements a test can address

Is each requirement a single numbered, measurable statement?

Why it mattersFDA's software guidance asks for requirements that are "measurable or objectively verifiable".30 One line holding three requirements gives a bundled trace nobody can audit.
A strong answer"Yes on new machines, and we fix legacy URSs when they change."
4
Locked templates with an owner

Are protocol templates approved, versioned and owned, with clear locked wording?

Why it mattersDrafting into a template only works if the template's wording is settled.
A strong answer"One per equipment class, with a named owner and change control."
5
Your trace, today

Does your matrix reach numbered test steps, through the specification and design record?

Why it mattersTracing to a section forces a full re-read, and tracing to a step lets you assess a change.
A strong answer"Yes, as an appendix approved with the protocol."
6
How a change reaches the author

When a source gets a new revision, does the validation author hear, with a record of what was assessed?

Why it mattersAnnex 15, section 11.4, expects the effect on documentation and validation to be evaluated.3
A strong answer"Change control names affected qualification documents, and we can show it."
7
Your position on AI in GMP documents

Has quality decided how an AI drafting aid would be assessed, validated and reviewed?

Why it mattersDraft Annex 22 and FDA's letter 722591 to one firm both leave the review to people, and the final EU text may differ.22,47,46
A strong answer"A written intended use and risk assessment, a review procedure, and someone watching the EU text."
8
A baseline you can defend

Do you have hours per protocol, review cycles and document-caused deviations from your own records?

Why it mattersNo measured public benchmark exists, so without your own numbers a pilot proves nothing.
A strong answer"Yes, from 20 recent protocols and the deviation log."
9
The days you get back · for reflection

If your engineers had three of their four days back on each protocol, what would they do first: design better tests, clear the requalification backlog, or take on work you now send to consultants? Not scored.

Clean records come first: three next steps for a qualification program, by score

0–6

Explore

Control your source records, number your requirements, lock your templates and time three protocols. All of it pays off with or without software.

7–11

Ready to pilot

Test on one machine with live changes and one protocol you have already approved by hand, with your quality group in the room from the start.

12–16

Ready to implement

Plan the connection to your document system, the template loading and your own validation of the tool, then move equipment class by class.

21 · Questions for any vendor

What to ask any validation protocol software vendor about citations, changes, signatures and AI (ask us too)

In shortAsk to see the behavior on your own files. The strongest test is a protocol you already approved by hand, with a value you know is missing. Be wary of any claim that a product is validated or compliant, since those words apply to your use of it.

AskA good answerA warning sign
Rules and claims
Is your product validated, GxP compliant or Part 11 compliant?"It carries controls that support your compliance. You validate your use, and here is what we give you to do it.""Yes, it's certified"
Which credentials do you hold?Named audits you can read, with dates and scopeA logo with no report behind it
How do you read draft Annex 22 for this use, and FDA's CSA guidance?States that both are as of a date, gives the CSA scope as device production and quality system software, and leaves the assessment with you"FDA's CSA covers all GxP" or "Annex 22 doesn't apply to us"
Drafting and values
Show me a value with no source. What happens?The field stays empty and flagged, and export waitsA plausible number appears
Can I open the page behind any value, from a scanned table too?Document, page and passage, in one click, on your scanA document name, with no page
Can the draft change our locked wording?No, and you can show me the check"The AI improves your template"
How do you stop a superseded revision being used?Status comes from my document system, and the revision used is recorded per section"Upload the latest files"
Trace and change
How deep does the trace go?Requirement, clause, design record and numbered test step, approved with the protocolA separate spreadsheet export
Change one line in my URS: what does the screen show?Old and new wording, marked tests, unaffected tests and what still holds"The document was updated"
What happens to a protocol that is already approved?A new version under change control; the old one stays as it wasEdit in place
People and records
Who can clear a flag or accept a draft?A named person with that role, with each decision recordedA confidence score clears it
What does a signature record, and can an author approve?Name, date, time, meaning, re-entered password. Roles kept apartA checkbox
Can I export the whole activity record and read it without your software?Yes, with who, what and when for each software and human stepOnly inside the product
Proof
What is your error rate on values, measured how?A method, a sample size, and an offer to measure on my filesA percentage faster, with no method
Who at a customer can say what it did, and what do they review?A reference call about how reviewers work, within what the customer allowsOnly hours saved
22 · A pilot plan

Twelve weeks on one machine: compare against a protocol you approved by hand, then run a live one

In shortPick one equipment class. Draft a protocol you already approved by hand, and compare it line by line. Then run a live one in parallel, push a real requirement change through it, and seed errors to test your reviewers. Finish with six numbers and a decision.

Twelve weeks: settle the assessment first, then compare, then run live
Your teamWith the vendor
Baseline from 20 past protocols
Intended use and risk assessment of the tool
Load one template and one machine's records
Draft a closed protocol and compare
Live protocol in parallel with the author
Push one real change; seed errors for reviewers
Measure, write up and decide
Week 036912

Illustrative · replace with your own numbers

Show the numbers
ActivityFromTo
Baseline from 20 past protocols03
Intended use and risk assessment of the tool03
Load one template and one machine's records14
Draft a closed protocol and compare36
Live protocol in parallel with the author59
Push one real change; seed errors for reviewers710
Measure, write up and decide1012

The six measures that decide a protocol drafting pilot

MeasureHowDecide on
Value accuracyEvery value in the closed protocol, against the approved one and the sourceWrong values and missing citations, by count. Investigate each difference: some will be errors in your original.
Honest gapsRemove a value from a source and see what happensIt must flag every time. One invented value is a stop.
Change impactUse a real past change with a known answer, and compare the marked testsTests missed, and tests marked without cause.
Reviewer catch rateSeed 10 errors in a draft, and count what reviewers findCompared with the same test on a hand-written protocol. Tells you about automation bias.54
Author hoursTime logs on the live protocol, against your baselineInclude checks, decisions and chasing.
Quality's verdictQA reads the file as an inspector wouldCan each requirement, value and decision be followed without the author present?
Deep questions to settle before you scale

Legacy protocols. Will you bring approved documents into the trace, or only at their next change?

Your SOP. Does your documentation procedure need to say what counts as "author" when software drafted the text and a person accepted it?

Regions. If the final EU Annex 22 keeps its wording on LLMs, what would you need to show? Keep your assessment in a form you can update.

Suppliers. Can suppliers send design specs in a form with stable clause numbers, and will you write that into purchase terms?

Device and drug under one roof. If one site runs both, which rule does each template answer to, and who says so?

Requalification. Annex 15, section 4, asks for evaluation at an appropriate frequency. Can the same trace feed your requalification reviews?

23 · FAQ

IQ, OQ and PQ questions: meaning, trace matrices, FDA, Annex 15, AI and paperless validation

In shortThe questions people search about qualification documents, each answered on its own.

What is validation document automation?

It is software that drafts qualification and validation documents, such as IQ, OQ and PQ protocols, reports and trace matrices, from a site's approved requirements, design specs and certificates. It cites the page behind each value and marks the tests a new revision touches. Qualified people still decide open questions, review and sign.

What is the difference between IQ, OQ and PQ?

Installation qualification (IQ) checks that equipment was installed as designed. Operational qualification (OQ) checks that it works across its operating range, including upper and lower limits. Performance qualification (PQ) checks that it performs its real job, consistently, with production material or a proven substitute. EU GMP Annex 15 describes all three and allows combining them where appropriate.

What is the difference between qualification and validation?

In drug manufacturing, equipment, utilities and systems are qualified, and processes are validated. Qualified equipment is a precondition for process validation. Device makers commonly use IQ, OQ and PQ as the stages of process validation itself. Computerized systems are validated under EU Annex 11 or equivalent rules.

Does FDA require IQ, OQ and PQ?

The drug rules in 21 CFR 211 do not use those words. They require equipment fit for its intended use, calibration and checks, and approved procedures. FDA's 2011 process validation guidance describes equivalent activities, and FDA warning letters do refer to IQ, OQ and PQ. Many firms use the labels because EU Annex 15 and ICH Q7 define them.

What should an OQ protocol include?

It should name the equipment, purpose, scope, responsibilities, references, prerequisites and test instruments with their calibration status, then each test step with its action, expected result and acceptance criterion. It should test upper and lower operating limits or worst case conditions, and it closes with how deviations are handled. Approval comes before execution.

Is a requirements traceability matrix required?

The EU and FDA drug GMP texts in force that we read do not demand a document by that name, but the links are expected. EU Annex 11 says user requirements should be traceable throughout the life cycle for computerized systems, and PIC/S tells inspectors to look for testing linked to specifications. Draft EU Annex 11 names the matrix as an example, and it is still a draft as of November 2026.

What happens to a protocol when the URS changes?

The change should go through change control, with its effect on documents and qualification assessed, as EU Annex 15 section 11.4 expects. Compare the new revision with the one the protocol used, list linked tests, and rewrite those affected in a new version for review and approval. Changes during execution are deviations, and after execution the question becomes requalification.

Can AI write a validation protocol?

AI can draft one for a person to check, and no text in force that we read bans that. Draft EU Annex 22 says generative AI and large language models should not be used in critical GMP applications, and that qualified people are responsible for outputs elsewhere; it remains a draft. FDA has told one firm it must review AI-generated documents. Your site should write down its own assessment.

What does draft EU GMP Annex 22 say about LLMs?

Section 1 of the July 2025 consultation draft says it does not apply to generative AI and large language models, and that such models should not be used in critical GMP applications. EudraLex Volume 4 lists no Annex 22 as of November 3, 2026. EMA's report on a June 30, 2026 workshop says the drafting group has discussed widening the scope, with no revised text published.

Does FDA's Computer Software Assurance guidance apply to equipment qualification?

Not as such. The current final version, dated February 3, 2026, covers computers and automated data processing systems used as part of production or the quality management system for medical devices. It is about software and is written for device makers. A drug maker's equipment qualification rests on 21 CFR 211, FDA's 2011 guidance or EU Annex 15.

How long does it take to write an OQ protocol?

We found no measured public benchmark, only vendor estimates with no study behind them. It depends on the equipment, your template and your records. The sample in this guide uses 4 working days by hand for one piece of process equipment, of which about one day is test design. Your document system's dates and a time log on three protocols will give your own number.

What is paperless validation, and does it remove the writing?

Paperless or digital validation means running test steps, results and approvals in software instead of on paper. It removes wet signatures and lost pages. Someone still has to find and enter the values, and to work out what a new revision touches, unless a drafting tool does that part too. One vendor's 2025 survey reports 58% of organizations using a digital system.

How did the QMSR change process validation for medical devices?

The Quality Management System Regulation took effect on February 2, 2026 and incorporates ISO 13485:2016 by reference. Process validation now rests on subclause 7.5.6 of that standard, and 21 CFR 820.75 is no longer in the rule. FDA's Form 483 counts for fiscal 2025 still cite the old section, which was in effect during those inspections.

Can software be validated, GxP compliant or Part 11 compliant out of the box?

No. A product can carry controls that support your compliance, such as audit trails, role separation and signatures with their meaning. GxP compliance belongs to your use of it, and you validate that use for its intended purpose. Treat any claim of a certified product with suspicion, and ask what the claim rests on.

24 · One-page summary

Writing a qualification protocol on one screen: the method, the rule dates and a 14-term glossary

Print this page

In shortThe whole guide on one screen: the method, the rules, the readiness bands and the terms.

The method
  1. Confirm each source is the current approved revision.
  2. Build the trace first, down to numbered test steps.
  3. Name who decides each gap and disagreement, and record why.
  4. Give every value a document and a page.
  5. Test upper and lower limits, and check instruments against the run date.
  6. Approve before execution. Later changes are deviations.
  7. Read each new revision against the one each document used, and write down what still holds.
  8. New version under change control. Never edit an approved document.
Where the rules stand
  • EU Annex 15: in operation since October 1, 2015. Revision planned: draft December 2026, publication April 2028.
  • EU Annex 11: January 2011 revision still current. Revised draft and draft Annex 22 pending; Q4 2026 is a target for final text.
  • 21 CFR 211: in force, with no IQ, OQ or PQ wording. FDA's process validation guidance dates from January 2011.
  • Devices: QMSR and ISO 13485:2016 since February 2, 2026.
  • FDA CSA: final February 3, 2026, device production and quality system software only.
  • AI: a person answers for it. Your documented assessment decides.
Your readiness
  • 0–6 Explore. Clean up records, templates and your baseline.
  • 7–11 Ready to pilot. One machine, one closed protocol, one live.
  • 12–16 Ready to implement. Connections, templates and your validation of the tool.
Fourteen terms

Acceptance criterion. The result that counts as a pass, fixed in advance.

ALCOA+. Data integrity principles: attributable, legible, contemporaneous, original, accurate, plus complete, consistent, enduring, available.

Change control. The procedure that assesses and approves a planned change.

Commissioning. Setting up and starting equipment, before qualification.

Deviation. A recorded departure from an approved plan, or a failed result.

DQ. Design qualification: the design checked against GMP and the URS.

FAT and SAT. Factory and site acceptance tests.

FDS. Functional design specification: the supplier's answer to the URS.

IQ, OQ, PQ. Installation, operational and performance qualification.

P&ID. Piping and instrumentation diagram.

Protocol. The approved test plan for a stage.

QMSR. FDA's device quality rule since February 2, 2026.

RTM. Requirements traceability matrix, from requirement to test.

URS. User requirements specification.

25 · Sources

Sources

Accessed November 2026. Regulatory status statements are as of November 2026. Warning letters are cited from FDA's own copies, for what each one says, by letter number. Survey figures from a validation software vendor are labeled as such.

  1. 21 CFR 211.63, Equipment design, size, and location, 2025 edition. govinfo.gov
  2. 21 CFR 211.68, Automatic, mechanical, and electronic equipment, 2025 edition. govinfo.gov
  3. European Commission, EudraLex Volume 4, EU GMP Annex 15: Qualification and Validation, March 30, 2015, in operation from October 1, 2015. health.ec.europa.eu
  4. ICH, Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients, Step 4, November 10, 2000, sections 12.20 to 12.30. database.ich.org
  5. FDA, About Warning and Close-Out Letters, read November 3, 2026. fda.gov
  6. FDA, warning letter 610444, March 10, 2021, over-the-counter drug manufacturer. fda.gov
  7. FDA, warning letter 727560, July 2, 2026, drug manufacturer. fda.gov
  8. European Commission and PIC/S, draft EU GMP Annex 11: Computerised Systems, consultation text, July 2025, sections 6 and 9. A draft, not in force. health.ec.europa.eu
  9. FDA, Process Validation: General Principles and Practices, guidance, January 2011, section on qualification of utilities and equipment. fda.gov
  10. PIC/S, PI 011-3, Good Practices for Computerised Systems in Regulated GxP Environments, September 25, 2007, sections 23.10 to 23.13. picscheme.org
  11. FDA, CDRH Learn slides by J. Tartal, Process Validation, November 4, 2015, on IQ and OQ under the former QS regulation, pointing to GHTF/SG3/N99-10:2004. We read the slides, not that guidance itself. fda.gov
  12. FDA, Quality Management System Regulation page, content current February 2, 2026: effective February 2, 2026, incorporating ISO 13485:2016 by reference. fda.gov
  13. FDA, Compliance Program 7382.850, Inspection of Medical Device Manufacturers, implementation date February 2, 2026. fda.gov
  14. World Health Organization, Technical Report Series 1019, Annex 3, Appendix 6: Guidelines on qualification, 2019. cdn.who.int
  15. ISPE, Baseline Guide Volume 5: Commissioning and Qualification, Second Edition, June 2019, publisher's page. The guide itself is sold; we read the page. ispe.org
  16. European Commission, EudraLex Volume 4, EU GMP Annex 11: Computerised Systems, revision January 2011, in operation from June 30, 2011. health.ec.europa.eu
  17. European Commission, EudraLex Volume 4 page, read November 3, 2026: Annex 11 listed at its January 2011 revision and no Annex 22. health.ec.europa.eu
  18. European Medicines Agency, inspectors working group three-year work plan, 2026 to 2028: Q4 2026 as the target for giving the Commission final text. ema.europa.eu
  19. FDA, Computer Software Assurance for Production and Quality Management System Software, final guidance, February 3, 2026, superseding the version of September 24, 2025. fda.gov
  20. European Medicines Agency, concept paper on the revision of EU GMP Annex 15, EMA/INS/GMP/163466/2026, corrigendum, section 4 timetable. It overtakes the Q4 2026 target for Annex 15 in the inspectors' work plan. ema.europa.eu
  21. European Commission, stakeholders' consultation on EudraLex Volume 4, Chapter 4, Annex 11 and new Annex 22, July 7 to October 7, 2025. health.ec.europa.eu
  22. European Commission and PIC/S, draft EU GMP Annex 22: Artificial Intelligence, consultation text, July 2025, section 1. A draft, not in force. picscheme.org
  23. 21 CFR 211.22, Responsibilities of quality control unit, 2025 edition, the newest on govinfo on November 3, 2026. govinfo.gov
  24. 21 CFR 211.100, Written procedures; deviations, 2025 edition. govinfo.gov
  25. FDA, Medical Devices; Quality System Regulation Amendments, final rule, 89 FR 7496, February 2, 2024: amended Part 820 shows Subparts C to O reserved. govinfo.gov
  26. 21 CFR 11.10, Controls for closed systems, 2025 edition. govinfo.gov
  27. 21 CFR 11.50, Signature manifestations, 2025 edition. govinfo.gov
  28. FDA, CDER Guidance Agenda, July 2026 posting: lists "Computer Software Assurance for AI-Based Systems in Drug Manufacturing and Clinical Investigations; Supplemental Guidance" as planned. An agenda does not bind CDER. fda.gov
  29. ISPE, GAMP 5 Guide, Second Edition, July 2022, publisher's page. The guide itself is sold; we read the page. ispe.org
  30. FDA, General Principles of Software Validation, final guidance, January 2002, section 5.2.2. Written for medical device software. fda.gov
  31. PIC/S, PI 006-3, Recommendations on Validation Master Plan, Installation and Operational Qualification, Non-Sterile Process Validation, Cleaning Validation, September 25, 2007, section 2.6. picscheme.org
  32. FDA, warning letter 728604, June 12, 2026, animal drug manufacturer. fda.gov
  33. FDA, Inspection Observations, spreadsheets for fiscal 2018 to fiscal 2025 (inspections ending by September 30, 2025), Drugs and Devices tabs, page current December 16, 2025. Counts are FDA's; sums across rows are ours. FDA says not every Form 483 is in the data, since some are manually prepared. fda.gov
  34. FDA, warning letter 736888, September 2, 2026, over-the-counter drug manufacturer. fda.gov
  35. FDA, warning letter 718601, January 7, 2026, drug manufacturer. fda.gov
  36. FDA, warning letter 711191, September 23, 2025, drug manufacturer. fda.gov
  37. FDA, warning letter 704786, June 12, 2025, drug manufacturer. fda.gov
  38. FDA, warning letter 700242, April 16, 2025, active ingredient manufacturer. fda.gov
  39. Mays and Mathias, "Measuring the rate of manual transcription error in outpatient point-of-care testing", J Am Med Inform Assoc 26(3), 2019, 269-272. Abstract read. pubmed.ncbi.nlm.nih.gov
  40. Garza et al., "Error rates of data processing methods in clinical research: a systematic review and meta-analysis", Int J Med Inform 195, 2025, 105749. Abstract read: 93 papers published 1978 to 2008. pubmed.ncbi.nlm.nih.gov
  41. Kneat, "2025 State of Validation: Validation Industry Annual Report", July 1, 2025, over 300 professionals. Kneat sells validation software. bioprocessonline.com
  42. Kneat, "The evolving landscape of validation programs in 2024", September 5, 2024, on its 2024 State of Validation report. Kneat sells validation software; the sample size is not stated. kneat.com
  43. "2026 State of Validation Report", sponsored content from Kneat in ISPE's Pharmaceutical Engineering, July 1, 2026, 614 professionals. ISPE says sponsored content is not endorsed or reviewed by it. ispe.org
  44. KI-Syndikat, use case page on process validation documentation, read November 3, 2026: gives its own estimate of hours for a protocol draft and says no representative study exists. A vendor page, in German. ki-syndikat.de
  45. FDA, Report on the State of Pharmaceutical Quality, fiscal year 2025, dated June 25, 2026: 1,248 drug quality assurance inspections. fda.gov
  46. FDA, warning letter 722591, April 2, 2026, drug manufacturer, on AI used to write CGMP documents. One firm, with other findings; no statement of general FDA policy. fda.gov
  47. European Medicines Agency, report of the multistakeholder workshop of June 30, 2026 on Annex 22, EMA/156789/2026. ema.europa.eu
  48. FDA, Considerations for the Use of Artificial Intelligence To Support Regulatory Decision-Making for Drug and Biological Products, draft guidance, January 2025. fda.gov
  49. European Medicines Agency, reflection paper on the use of artificial intelligence in the medicinal product lifecycle, adopted September 9, 2024, section 2.3.6. ema.europa.eu
  50. European Medicines Agency, "EMA and FDA set common principles for AI in medicine development", January 14, 2026. ema.europa.eu
  51. ISPE, GAMP Guide: Artificial Intelligence, July 2025, publisher's page. The guide itself is sold; we read the page. ispe.org
  52. European Commission, AI Act page, on Regulation (EU) 2026/1744: in force July 27, 2026; Annex III rules December 2, 2027; Annex I rules August 2, 2028. digital-strategy.ec.europa.eu
  53. Asgari et al., npj Digital Medicine, 2025, a framework for hallucination and omission rates in clinical notes generated with large language models. Abstract read. All authors worked for the company behind the pipeline. pubmed.ncbi.nlm.nih.gov
  54. Goddard, Roudsari and Wyatt, "Automation bias: a systematic review of frequency, effect mediators, and mitigators", J Am Med Inform Assoc 19(1), 2012, 121-127. Abstract read. pubmed.ncbi.nlm.nih.gov
  55. MHRA, GXP Data Integrity Guidance and Definitions, March 2018, section 3.10 on ALCOA and ALCOA+. assets.publishing.service.gov.uk
  56. O*NET OnLine, Validation Engineers, 17-2112.02, U.S. Department of Labor: 2025 median wage of $49.25 an hour and $102,440 a year, reported for the related occupation Industrial Engineers. onetonline.org
  57. ICH, Q9(R1) Quality Risk Management, final, adopted January 18, 2023. database.ich.org
Next step

See it on your own protocols.

Explore the solution, or bring one URS, one design spec and one approved protocol template, and we will draft a protocol with you, every value pointing to its page, for your people to check and sign.

botminds.ai The complete guide to validation document automation · November 2026. Bioreactor BR-204, Plant 3 Leiden, Plant 5 Galway, every person, document number, requirement and figure in the example and the screens are fictional. Regulatory status is as of November 2026; check the sources before relying on it. This guide is general information and is not legal advice. Software cannot itself be validated for your use, GxP compliant or certified: it can carry controls that support your compliance, and you qualify your equipment and validate your use of the software.